News Articles Tagged: HDM-2 Interaction

The Therapeutic Potential of PNC-27: A Breakthrough in Anti-Cancer Peptide Research

Explore the therapeutic potential of PNC-27, a synthetic anti-cancer peptide that targets cancer cell membranes for selective necrosis, offering a novel p53-independent treatment strategy.

PNC-27: A New Era in Targeted Cancer Therapeutics

Discover how PNC-27, a synthetic anti-cancer peptide, is paving the way for more effective and safer cancer treatments through selective cell membrane targeting and necrosis induction.